Identifying Rare Subtypes of CD8 T-cells Using Single Cell Reactors
使用单细胞反应器鉴定 CD8 T 细胞的稀有亚型
基本信息
- 批准号:9262845
- 负责人:
- 金额:$ 27.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-15 至 2020-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptor Signaling ProteinAdoptionAreaBacteriaBiological AssayCD8-Positive T-LymphocytesCD8B1 geneCell RespirationCell SeparationCell SurvivalCell physiologyCellsCellular Metabolic ProcessCharacteristicsComputer AnalysisComputing MethodologiesCoupledDetectionDevicesDiseaseDyesEncapsulatedFatty AcidsFluorocarbonsFutureGenesGeneticGrowth FactorHomeostasisImmuneImmune responseImmunotherapyIndividualInfectionInflammatoryLectinLinkMalignant NeoplasmsMeasuresMemoryMetabolicMicrofluidic MicrochipsMicrofluidicsModelingMolecularMolecular ProfilingOilsPathway interactionsPhasePhysiologicalPopulationPopulation DynamicsProliferatingRoleSecondary toSorting - Cell MovementSpeedSurfaceSystemT cell differentiationT cell responseT-LymphocyteT-Lymphocyte SubsetsTRAF6 geneTechniquesTestingVariantVirusWithdrawaladaptive immune responsecell mediated immune responsecell typecytokinedetectorfatty acid metabolisminterestmetabolic profilemolecular markernovelprecursor cellprogramspublic health relevancereceptorresponsesecondary infectionsingle cell analysistranscription factortranscriptometranscriptome sequencingtranscriptomics
项目摘要
DESCRIPTION (provided by applicant): Understanding the molecular characteristics of immune cells, such as memory cells, is critical for understanding adaptive immune response. In particular, gaps remain concerning our understanding of whether metabolic changes can drive T cell differentiation (and if so, how), or rather, if these changes are simply by-products of responses to external factors (e.g., cytokines) encountered during the course of differentiation. Further, it remains unclear whether there exists a direct causal relationship between modulation of the fatty acid metabolizing machinery and the critical cell fate decision(s) dictating the transition from an effector to a memory cell, and whether metabolic states in individual cells can be correlated with larger population dynamics. We seek to identify a panel of molecular markers will allow future functional testing and identification of fate decision pathways for this criticaly important cell type. To overcome the limitations of single cell molecular profiling and standard metabolic assays, we will develop a novel microfluidics device that will enable rapid single cell metabolic profiling and sorting coupled to single cell transcriptome profiling. Utilizing this devie, we will isolate rare subpopulations of CD8 T cells by their metabolic signatures and identify molecular markers for each subpopulation. In Aim 1, we will develop a microfluidics system for rapid single cell metabolic profiling and sorting. Specifically, a high-speed fluorocarbon (FC) oil
droplet cell encapsulating microfluidics device coupled to metabolic functional dye probes and high-content detector sorting system will be developed. The device will be optimized for speed, capture efficiency, cell viability, high-speed detection, and sorting. In Aim 2, we will identify molecular markers in sub-population of CD8 T cells during response program using single cell RNASeq. To achieve this aim, we will couple the microfluidics device with select functional dyes to characterize individual cell's metabolic states. The profiles of the metabolic readouts will be analyzed by computational methods to identify distinct subpopulations. These metabolic signatures will be used to gate the cells by the microfluidics device in a sorting mode and the resulting subpopulations of cells will be analyzed by single cell RNASeq to identify molecular markers for each subtype. The results of this study will lead to future studies on the role of identified molecules in T cell response dynamics. Understanding the molecular basis of T cell functional subtypes will not only enhance understanding of our body's response to diseases, it will lead to translational applications in areas such as cancer immune-therapy.
描述(由申请人提供):了解免疫细胞的分子特征,如记忆细胞,对于理解适应性免疫反应至关重要。特别是,关于代谢变化是否能够驱动T细胞分化(如果是,如何驱动),或者更确切地说,这些变化是否只是在分化过程中遇到的外部因素(例如细胞因子)反应的副产品,我们仍然存在差距。此外,目前尚不清楚脂肪酸代谢机制的调节与关键细胞命运决定(S)之间是否存在直接的因果关系,该决定决定了从效应器到记忆细胞的转变,以及单个细胞的代谢状态是否可以与更大的群体动态相关。我们寻求确定一组分子标记,以便进行未来的功能测试,并确定这一至关重要的细胞类型的命运决定途径。为了克服单细胞分子图谱和标准代谢分析的局限性,我们将开发一种新型的微流控设备,使快速的单细胞代谢图谱和分选与单细胞转录组图谱相结合。利用这一设备,我们将根据CD8T细胞的代谢特征分离稀有的亚群,并为每个亚群确定分子标记。在目标1中,我们将开发一种用于快速单细胞代谢图谱和分选的微流控系统。具体地说,一种高速氟碳(FC)油
将开发与代谢功能染料探针和高含量检测器分选系统耦合的液滴细胞微流控装置。该设备将在速度、捕获效率、细胞活力、高速检测和分选方面进行优化。在目标2中,我们将使用单细胞RNAseq在应答程序中识别CD8T细胞亚群中的分子标记。为了实现这一目标,我们将把微流控设备与精选的功能染料结合起来,以表征单个细胞的代谢状态。代谢读数的分布将通过计算方法进行分析,以确定不同的亚群。这些代谢特征将被微流控设备以分类模式用于对细胞进行选通,由此产生的细胞亚群将通过单细胞RNAseq进行分析,以确定每个亚型的分子标记。这项研究的结果将导致未来对识别的分子在T细胞反应动力学中的作用的研究。了解T细胞功能亚型的分子基础不仅将增强我们对身体对疾病的反应的了解,还将导致在癌症免疫治疗等领域的翻译应用。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YONGWON CHOI其他文献
YONGWON CHOI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YONGWON CHOI', 18)}}的其他基金
IgSF11 Signaling Controls Osteoclast Maturation and Pathogenic Bone Loss
IgSF11 信号传导控制破骨细胞成熟和致病性骨质流失
- 批准号:
10544787 - 财政年份:2022
- 资助金额:
$ 27.46万 - 项目类别:
IgSF11 Signaling Controls Osteoclast Maturation and Pathogenic Bone Loss
IgSF11 信号传导控制破骨细胞成熟和致病性骨质流失
- 批准号:
10337682 - 财政年份:2022
- 资助金额:
$ 27.46万 - 项目类别:
Regulation of T cell responses to oral antigens
T 细胞对口腔抗原反应的调节
- 批准号:
9306661 - 财政年份:2017
- 资助金额:
$ 27.46万 - 项目类别:
Dendritic Cell-Mediated Oral Antigen Tolerance and the Lung
树突状细胞介导的口腔抗原耐受和肺
- 批准号:
9238657 - 财政年份:2016
- 资助金额:
$ 27.46万 - 项目类别:
Cell Adhesion Regulation of Osteoclast Maturation
破骨细胞成熟的细胞粘附调节
- 批准号:
9899199 - 财政年份:2016
- 资助金额:
$ 27.46万 - 项目类别:
Dendritic Cell-Mediated Oral Antigen Tolerance and the Lung
树突状细胞介导的口腔抗原耐受和肺
- 批准号:
9086712 - 财政年份:2016
- 资助金额:
$ 27.46万 - 项目类别:
Identifying Rare Subtypes of CD8 T-cells Using Single Cell Reactors
使用单细胞反应器鉴定 CD8 T 细胞的稀有亚型
- 批准号:
9086041 - 财政年份:2016
- 资助金额:
$ 27.46万 - 项目类别:
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 27.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 27.46万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 27.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 27.46万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 27.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 27.46万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 27.46万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 27.46万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 27.46万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 27.46万 - 项目类别:
Standard Grant














{{item.name}}会员




